Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Atea Pharmaceuticals Inc.
Sponsor

Atea Pharmaceuticals Inc.

United States 225 Franklin Street Suite 2100, 02110-2856, United States

About the sponsor

Research activity includes COVID-19 in high-risk outpatients, with attention to reducing hospitalization and mortality in individuals receiving supportive care.

  • Antiviral therapy
  • Outpatient management
  • Hospitalization prevention
  • Mortality reduction

The sponsor’s clinical focus in this area centers on treatment options for symptomatic viral infection outside the hospital setting.

About Specializations

Atea Pharmaceuticals Inc. runs clinical trials in conditions such as Chronic hepatitis C, COVID-19, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Chronic hepatitis C

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ruzasvir
  • Sponsor:Atea Pharmaceuticals Inc.

COVID-19

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nirmatrelvir
  • Sponsor:Atea Pharmaceuticals Inc.

Chronic hepatitis C

Not recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ruzasvir
  • Sponsor:Atea Pharmaceuticals Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.